Cochlear reports record full year results
Tuesday, 10 August, 2010
Cochlear released its full year results today reporting a 19 percent increase in net profit to $155.2 million on the back of record total revenues of $784.8 million.
The company reported Cochlear implant (CI) sales, including accessories and sound processor upgrades, of $603.7 million, down 2 percent, up 13 percent in constant currency.
A total of 21,023 implants were sold during the year, a 20 percent increase on the previous 12 months. This was largely driven by the launch of the new Cochlear Nucleus 5 implant in the first half. The majority of implants sold in the second half of the year were of the Nucleus 5. Sales of the Cochlear Baha 3 complete hearing system, currently being launched in major markets, were up nine percent to $92.5 million.
US sales provided the biggest boost to the overall result, up 18 percent to $307.6 million, followed by the EMEA (Europe, Middle East and Africa) where sales increased seven percent to $291.5 million. Sales to the Asia Pacific increased five percent to $97.1 million, which included 500 units sold into China as part of a donation program. Cochlear also reported a foreign currency gain of $38.6 million.
R&D spend fell two percent to $94.9 million for the year. This contributed to margin expansion with EBIT/Total Revenue improving four percent to 30 percent. Cochlear declared a final partially franked dividend of $1.05 (franked to 60 percent) to be paid in September. The full dividend for the year was up 14 percent to $2.00.
The result was roughly in line with market expectations, however it faield to impress investors with the stock shedding almost two percent to close today at $69.86. Analysts noted that Cochlear’s refusal to give much guidance for future results was a key reason for the negative reaction.
Speaking about the results on Australian television on Tuesday, Cochlear CEO Dr Chris Roberts noted however, that the company expects to realise a higher level of product innovation over the next few years following the completion at the end of this year of its new global headquarters at Macquarie University.
New henipaviruses discovered in bats
Researchers have identified new viruses, bacteria and parasites among bats in orchards in...
Placebo pain relief works differently across the human body
Researchers have used placebo pain relief to uncover a map-like system in the brainstem that...
COVID infection ages blood vessels, particularly in women
Blood vessels gradually become stiffer with age, but a new study by international researchers...
